encainide has been researched along with Cardiovascular Stroke in 37 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (37.84) | 18.7374 |
1990's | 22 (59.46) | 18.2507 |
2000's | 1 (2.70) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baizman, ER; Becker, C; Bell, RH; Birsner, NC; Bohnet, EA; Busacca, CA; Carabateas, PM; Chadwick, CC; Gruett, MD; Johnson, RE | 1 |
Hellestrand, KJ | 1 |
Dawson, AK; Duff, HJ; Roden, DM; Smith, RF; Woosley, RL | 1 |
Mason, JW; Oyer, PE; Stinson, EB; Winkle, RA | 1 |
Bigger, JT; Fleiss, JL; Rolnitzky, LM; Steinman, RC | 1 |
Anderson, JL; Carlson, M; Davies, R; Duff, HJ; Greene, HL; Hallstrom, AP; Huther, M; Kammerling, JM; Romhilt, DW | 1 |
Duff, HJ; Laganiere, S; Lester, W; Rude, E; Stemler, M; Thannhauser, T | 1 |
Gehret, JR; Kothstein, T; Lynch, JJ; Stupienski, RF; Wallace, AA | 1 |
DeMaria, A; Gottlieb, S; Greene, HL; Hallstrom, A; Huther, M; Pratt, CM; Young, JB | 1 |
Anderson, JL; Buckingham, TA; Carlson, MD; Carson, PE; Hallstrom, A; Henthorn, RW; Platia, EV | 1 |
Anderson, JL; Capone, RJ; Cohen, JD; Epstein, AE; Hallstrom, AP; Liebson, PR; Rogers, WJ; Seals, AA; Wyse, DG | 1 |
Brooks, MM; Gorkin, L; Kellen, J; Morris, M; Pawitan, Y; Schoenberger, JA; Schron, EB; Shumaker, S; Verter, J; Wiklund, I | 1 |
Dwyer, EM; Echt, DS; Greenberg, HM; Hochman, JS; Peters, RW; Steinberg, JS | 1 |
Brezsnyak, ML; Campion, J; Corum, J; Ettinger, A; Kellen, JC; McBride, R; Schron, E; Thomas, S; Todd, L | 1 |
Tonkin, AM | 1 |
Brunden, MN; Buchanan, LV; Gibson, JK; Kabell, G; Turcotte, UM | 1 |
Greene, HL; Henthorn, RW; Katz, RJ; Roden, DM; Salerno, DM; Woosley, RL | 1 |
Akiyama, T; Barker, AH; Campbell, WB; Friedman, L; Josephson, RA; Keller, M; Papa, L; Pawitan, Y; Rubbert, P | 1 |
Akiyama, T; Greenberg, H; Kuo, CS; Pawitan, Y; Reynolds-Haertle, RA | 1 |
Kerin, NZ | 1 |
Arensberg, D; Baker, A; Barker, AH; Echt, DS; Friedman, L; Greene, HL; Liebson, PR; Mitchell, LB; Obias-Manno, D; Peters, RW | 1 |
Bigger, JT; Epstein, AE; Hallstrom, AP; Reynolds-Haertle, RA; Romhilt, DW; Wyse, DG | 1 |
Cohen, JD; Hallstrom, A; Mahmarian, J; McBride, R; Steinberg, JS; Wyse, DG | 1 |
Capone, RJ; el-Sherif, N; Geraci, TS; Handshaw, K; Morganroth, J; Pawitan, Y; Schlant, RC; Waldo, AL | 1 |
Moye, LA; Pratt, CM | 1 |
Barker, AH; Capone, RJ; Echt, DS; Greene, HL; Hallstrom, AP; McBride, R; Richardson, DW; Roden, DM | 1 |
Anderson, JL; Barker, AH; Fowles, RE; Griffith, LS; Hallstrom, AP; Ledingham, RB; Reiffel, JA; Young, JB; Yusuf, S | 1 |
Coyle, JD; Schaal, SF | 1 |
Ruskin, JN | 1 |
Kinnaird, AA; Man, RY | 1 |
Camm, AJ; Garratt, C; Ward, DE | 1 |
Gomoll, AW | 1 |
3 review(s) available for encainide and Cardiovascular Stroke
Article | Year |
---|---|
Comparison of the efficacy of newly developed antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Coronary Disease; Encainide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Piperidines; Tachycardia; Tocainide; Ventricular Fibrillation | 1984 |
Treatment of ventricular arrhythmias after CAST.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Death, Sudden, Cardiac; Electrocardiography, Ambulatory; Encainide; Flecainide; Heart Ventricles; Humans; Moricizine; Myocardial Infarction; Ventricular Function, Left | 1992 |
The Cardiac Arrhythmia Suppression Trial: background, interim results and implications.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Flecainide; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Research Design; Survival Analysis | 1990 |
24 trial(s) available for encainide and Cardiovascular Stroke
Article | Year |
---|---|
Predicting mortality after myocardial infarction from the response of RR variability to antiarrhythmic drug therapy.
Topics: Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Electrocardiography, Ambulatory; Encainide; Female; Flecainide; Follow-Up Studies; Heart Conduction System; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction; Risk Factors; Signal Processing, Computer-Assisted | 1994 |
Time to arrhythmic, ischemic, and heart failure events: exploratory analyses to elucidate mechanisms of adverse drug effects in the Cardiac Arrhythmia Suppression Trial.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Double-Blind Method; Encainide; Flecainide; Heart Failure; Humans; Moricizine; Myocardial Infarction; Myocardial Ischemia; Risk Factors; Survival Analysis; Time Factors | 1995 |
Relations between heart failure, ejection fraction, arrhythmia suppression and mortality: analysis of the Cardiac Arrhythmia Suppression Trial.
Topics: Arrhythmias, Cardiac; Electrocardiography; Encainide; Female; Flecainide; Heart Failure; Humans; Male; Middle Aged; Moricizine; Multivariate Analysis; Myocardial Infarction; Predictive Value of Tests; Prognosis; Prospective Studies; Regression Analysis; Stroke Volume; Survival Analysis | 1995 |
Interaction of baseline characteristics with the hazard of encainide, flecainide, and moricizine therapy in patients with myocardial infarction. A possible explanation for increased mortality in the Cardiac Arrhythmia Suppression Trial (CAST).
Topics: Arrhythmias, Cardiac; Encainide; Female; Flecainide; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction; Statistics as Topic; Survival Analysis | 1994 |
Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction. The original design concept of the Cardiac Arrhythmia Suppression Trial (CAST).
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Female; Flecainide; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction; Survival Analysis; Ventricular Function, Left | 1993 |
Psychosocial predictors of mortality in the Cardiac Arrhythmia Suppression Trial-1 (CAST-1).
Topics: Arrhythmias, Cardiac; Chi-Square Distribution; Encainide; Flecainide; Humans; Moricizine; Myocardial Infarction; Prognosis; Psychological Tests; Psychology, Social; Regression Analysis; Social Support | 1993 |
Interaction of ischaemia and encainide/flecainide treatment: a proposed mechanism for the increased mortality in CAST I.
Topics: Angina Pectoris; Anti-Arrhythmia Agents; Databases, Factual; Death, Sudden, Cardiac; Drug Interactions; Encainide; Flecainide; Heart Failure; Humans; Myocardial Infarction; Myocardial Ischemia; Retrospective Studies; Syncope; United States | 1995 |
The Cardiac Arrhythmia Suppression Trial: Implications for nursing practice.
Topics: Aged; Anti-Arrhythmia Agents; Critical Care; Death, Sudden, Cardiac; Encainide; Female; Flecainide; Humans; Male; Middle Aged; Monitoring, Physiologic; Moricizine; Myocardial Infarction; Nursing Assessment; Survival Rate; Ventricular Premature Complexes | 1996 |
The Cardiac Arrhythmia Suppression Trial: first CAST ... then CAST-II.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Double-Blind Method; Encainide; Flecainide; Humans; Moricizine; Myocardial Infarction; Survival Rate | 1992 |
Effects of advancing age on the efficacy and side effects of antiarrhythmic drugs in post-myocardial infarction patients with ventricular arrhythmias. The CAST Investigators.
Topics: Adult; Age Factors; Aged; Aging; Arrhythmias, Cardiac; Drug Therapy, Combination; Encainide; Flecainide; Follow-Up Studies; Humans; Logistic Models; Middle Aged; Moricizine; Myocardial Infarction; Prognosis; Stroke Volume | 1992 |
Increased risk of death and cardiac arrest from encainide and flecainide in patients after non-Q-wave acute myocardial infarction in the Cardiac Arrhythmia Suppression Trial. CAST Investigators.
Topics: Cardiac Complexes, Premature; Cause of Death; Drug Combinations; Electrocardiography; Encainide; Female; Flecainide; Follow-Up Studies; Heart Arrest; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction; Placebos; Risk Factors; United States | 1991 |
Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.
Topics: Actuarial Analysis; Anilides; Arrhythmias, Cardiac; Electrocardiography; Encainide; Flecainide; Follow-Up Studies; Heart Arrest; Heart Failure; Humans; Morbidity; Myocardial Infarction; Patient Compliance | 1991 |
Events in the Cardiac Arrhythmia Suppression Trial (CAST): mortality in the entire population enrolled.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Double-Blind Method; Encainide; Female; Flecainide; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction | 1991 |
Events in the Cardiac Arrhythmia Suppression Trial (CAST): mortality in patients surviving open label titration but not randomized to double-blind therapy.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Female; Flecainide; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction; Regression Analysis | 1991 |
Events in the cardiac arrhythmia suppression trial: baseline predictors of mortality in placebo-treated patients.
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chi-Square Distribution; Double-Blind Method; Encainide; Female; Flecainide; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Placebos; Proportional Hazards Models; Prospective Studies; Reference Values; Risk Factors | 1991 |
The Cardiac Arrhythmia Suppression Trial: background, interim results and implications.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Flecainide; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Research Design; Survival Analysis | 1990 |
Recruitment and baseline description of patients in the Cardiac Arrhythmia Pilot Study. The Cardiac Arrhythmia Pilot Study (CAPS) investigators.
Topics: Anilides; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Electrocardiography; Encainide; Feasibility Studies; Female; Flecainide; Humans; Imipramine; Male; Middle Aged; Moricizine; Myocardial Infarction; Phenothiazines; Pilot Projects; Random Allocation; Stroke Volume; United States | 1988 |
Congestive heart failure after acute myocardial infarction in patients receiving antiarrhythmic agents for ventricular premature complexes (Cardiac Arrhythmia Pilot Study).
Topics: Anilides; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Double-Blind Method; Encainide; Female; Flecainide; Heart Failure; Humans; Imipramine; Male; Middle Aged; Moricizine; Myocardial Infarction; Phenothiazines; Random Allocation; Stroke Volume | 1989 |
Relation of baseline characteristics to suppression of ventricular arrhythmias during placebo and active antiarrhythmic therapy in patients after myocardial infarction.
Topics: Anilides; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Encainide; Flecainide; Humans; Imipramine; Moricizine; Multicenter Studies as Topic; Myocardial Infarction; Phenothiazines; Pilot Projects; Random Allocation; Statistics as Topic; Stroke Volume | 1989 |
Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.
Topics: Aged; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Death, Sudden; Encainide; Female; Flecainide; Follow-Up Studies; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction; Phenothiazines; Random Allocation | 1989 |
An interim perspective on the removal of encainide and flecainide from the cardiac arrhythmia suppression trial.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Encainide; Ethics, Medical; Flecainide; Humans; Myocardial Infarction; United States; United States Food and Drug Administration | 1989 |
Lessons from the cardiac arrhythmia suppression trial.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Encainide; Flecainide; Humans; Moricizine; Myocardial Infarction; Phenothiazines; United States | 1989 |
Flecainide and CAST.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Evaluation; Encainide; Flecainide; Humans; Multicenter Studies as Topic; Myocardial Infarction; Product Surveillance, Postmarketing; Random Allocation | 1989 |
Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Encainide; Female; Flecainide; Heart Failure; Humans; Imipramine; Male; Middle Aged; Moricizine; Myocardial Infarction; Phenothiazines; Random Allocation; Stroke Volume | 1988 |
11 other study(ies) available for encainide and Cardiovascular Stroke
Article | Year |
---|---|
4,5-Dihydro-1-phenyl-1H-2,4-benzodiazepines: novel antiarrhythmic agents.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzodiazepines; Cats; Disease Models, Animal; Dogs; Guinea Pigs; Heart Ventricles; Male; Myocardial Contraction; Myocardial Infarction; Potassium Channels; Rats; Rats, Sprague-Dawley; Refractory Period, Electrophysiological; Sodium Channels; Structure-Activity Relationship | 1993 |
[Caution in therapy of ventricular extrasystole. Staying safe with electrolytes].
Topics: Anti-Arrhythmia Agents; Aspartic Acid; Cardiac Complexes, Premature; Cause of Death; Drug Combinations; Encainide; Flecainide; Humans; Myocardial Infarction; Potassium; Randomized Controlled Trials as Topic; Survival Rate; Treatment Outcome | 2002 |
Differential effects of O-demethyl encainide on induced and spontaneous arrhythmias in the conscious dog.
Topics: Anilides; Animals; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Dogs; Electrocardiography; Encainide; Myocardial Infarction; Ventricular Fibrillation | 1984 |
Mechanisms of ventricular tachycardia: wide, complex ignorance.
Topics: Anilides; Anti-Arrhythmia Agents; Chronic Disease; Electrophysiology; Encainide; Humans; Myocardial Infarction; Recurrence; Tachycardia | 1981 |
Proarrhythmia of a class Ic drug: suppression by combination with a drug prolonging repolarization in the dog late after infarction.
Topics: Animals; Barium Compounds; Chlorides; Death, Sudden; Dogs; Drug Therapy, Combination; Electric Stimulation; Encainide; Myocardial Infarction; Tachycardia, Ventricular | 1995 |
Demonstration of proarrhythmic activity with the class IC antiarrhythmic agent encainide in a canine model of previous myocardial infarction.
Topics: Animals; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Disease Models, Animal; Dogs; Electric Stimulation; Electrophysiology; Encainide; Female; Heart Ventricles; Injections, Intravenous; Male; Myocardial Infarction | 1993 |
Effects of ibutilide on spontaneous and induced ventricular arrhythmias in 24-hour canine myocardial infarction: a comparative study with sotalol and encainide.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dogs; Electrocardiography; Encainide; Hemodynamics; Myocardial Infarction; Sotalol; Sulfonamides | 1992 |
Crime, misdemeanor, and arrhythmia decoding CAST.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Encainide; Flecainide; Heart Ventricles; Humans; Moricizine; Myocardial Infarction; Randomized Controlled Trials as Topic; Research Design; Risk Factors | 1991 |
The cardiac arrhythmia suppression trial (CAST).
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden; Encainide; Flecainide; Humans; Myocardial Infarction; Pilot Projects | 1989 |
Electrophysiological effects of encainide and its metabolites in normal canine Purkinje fibers and Purkinje fibers surviving infarction.
Topics: Action Potentials; Anilides; Animals; Anti-Arrhythmia Agents; Dogs; Encainide; Female; Heart Conduction System; In Vitro Techniques; Male; Myocardial Infarction; Purkinje Fibers | 1989 |
Assessment of drug effects on spontaneous and induced ventricular arrhythmias in a 24-h canine infarction model.
Topics: Anilides; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Dogs; Electrocardiography; Encainide; Female; Flecainide; Male; Myocardial Infarction; Sotalol | 1987 |